Fan et al. proposed identifying CD4+ T cell-derived CD161+CD39+ and CD39+CD73+ microparticles as new biomarkers for rheumatoid arthritis evaluation (11). This evidence concerns the gene ENTPD1 and rheumatoid arthritis.